IB1001 Articles
Ipsen and Inspiration Biopharma sell IB1001 rights to Cangene
6 February 2013
Ipsen and Inspiration Biopharma in deal with Baxter for OBI-1
24 January 2013
Ipsen and Inspiration renegotiate hemophilia agreement
22 August 2012
Showing 1-4 of 4 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
